ARCHIVES

FDA’s Kweder cites Society of Professional Journalists’ Code of Ethics–incorrectly, SPJ says.

This article is from The Cancer Letter archive.

Vol. 31 No. 09 | March 4, 2005

Download PDF Visit The Full Archive

Related Articles

Phase III Trebananib Trial Fails OS Endpoint In Recurrent Platinum-Resistant Ovarian Cancer

November 28, 2014

Modeling: Like The Sims But No Graphics

November 26, 2010

New RFAs Released: Kaposi Sarcoma; Rare Tumors; Biochemical Epidemiology; Dietary Questionnaire; Role of Nicotine

August 20, 1982

NCCAM Awards To Establish Two Cancer Research Centers.

October 13, 2000

RFP: Intellectual Property.

March 31, 2000

Revlimid Extends Time To Progression Compared To Placebo In Phase III Trial

December 25, 2009